Drug Patent Expirations in November 2007

Courtesy of DrugPatentWatch.com:

Drug Patent Expirations in November 2007
*Drugs may be covered by more than one patent

Tradename Applicant Generic Name Patent Number Patent Expiration
ANDRODERM Watson Labs testosterone 4,849,224 NOV 12,2007
ANDRODERM Watson Labs testosterone 4,983,395 NOV 12,2007
AVITA Mylan Bertek tretinoin 4,971,800 NOV 20,2007
COMTAN Orion entacapone 4,963,590 NOV 27,2007
ELOCON Schering mometasone furoate 4,775,529 NOV 21,2007
FLECTOR Inst Biochem diclofenac epolamine 4,948,805 NOV 09,2007
MERIDIA Abbott sibutramine hydrochloride 4,929,629 NOV 29,2007
MYLOTARG Wyeth Pharms Inc gemtuzumab ozogamicin 4,970,198 NOV 30,2007
PROVIGIL Cephalon modafinil 4,927,855 NOV 22,2007
STALEVO 100 Orion carbidopa; entacapone; levodopa 4,963,590 NOV 27,2007
STALEVO 150 Orion carbidopa; entacapone; levodopa 4,963,590 NOV 27,2007
STALEVO 50 Orion carbidopa; entacapone; levodopa 4,963,590 NOV 27,2007
TOPROL-XL Astrazeneca metoprolol succinate 4,927,640 NOV 22,2007
TYLENOL (CAPLET) Mcneil Cons acetaminophen 4,968,509 NOV 06,2007
URSO 250 Axcan Scandipharm ursodiol 4,859,660 NOV 19,2007
URSO FORTE Axcan Scandipharm ursodiol 4,859,660 NOV 19,2007

Courtesy of DrugPatentWatch.com


   No Comments yet


  1. Richard
      Nov 6, 2007

    cephalon PAID TO HAVE THIS PATENT EXTENDED. BEYOND EXPIRATION.I PAY $10.00 PLUS FOR ONE PILL, TAKE THREE A DAY, $30.00 DAILY. MODAFINAL, THE GENERIC, IS NOT AVAILABLE IN THE U.S. A GOVERNMENT “FOR THE PEOPLE” .A FARCE WHEN BIG DRUG MANUFACTURERS PAY TO CONTROL ITS PATENT EXPIRATION

Leave a Reply